Market Research on Generics Top 5 Emerging Markets Industry Guide 2015-2024

Source: https://www.researchbymarkets.com/report/generics-top-5-emerging-markets-industry-guide-2015-2024-645768.html

Generics Top 5 Emerging Markets Industry Guide 2015-2024

Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

– These countries contributed $99,860.0 million to the global generics industry in 2019, with a compound annual growth rate (CAGR) of 8.9% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $130,298.8 million in 2024, with a CAGR of 5.5% over the 2019-24 period.
– Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $69,811.0 million in 2019. This was followed by India and Mexico with a value of $16,448.5 and $6,634.9 million, respectively.
– China is expected to lead the generics industry in the top five emerging nations, with a value of $89,577.3 million in 2024, followed by India and Mexico with expected values of $23,292.4 and $8,408.8 million, respectively.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
– Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
– Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to Buy

– What was the size of the emerging five generics market by value in 2019?
– What will be the size of the emerging five generics market in 2024?
– What factors are affecting the strength of competition in the emerging five generics market?
– How has the market performed over the last five years?
– How large is the emerging five generics market in relation to its regional counterparts?

Companies Mentioned:
Aspen Pharmacare Holdings Ltd
Teva Pharmaceutical Industries Limited
Adcock Ingram Holdings Ltd
Pfizer Inc.
Sanofi SA
EMS SA
Ache Laboratorios Farmaceuticos SA
Eurofarma Laboratorios SA
Mylan N.V.
China Grand Pharmaceutical and Healthcare Holdings Limited
Sun Pharmaceutical Industries Ltd
Lupin Ltd
Aurobindo Pharma Ltd
Cipla Limited


For queries regarding this report: https://www.researchbymarkets.com/sample-request/645768

Contact Us:
ResearchByMarkets.com
Ritesh Tiwari, Director
enquiry@researchbymarkets.com
USA: +1-800-416-3124
https://www.researchbymarkets.com
https://www.researchbymarkets.com/aboutus

Follow us on Social Media:
Facebook: https://www.facebook.com/researchbymarkets/
LinkedIn: https://www.linkedin.com/company/researchmarkets
Twitter: https://twitter.com/ResearchByMrkts

Ritesh Tiwari is the Founder of Research By Markets. He has more than 7 years experience in the Market Research industry and a total experience spanning 18+ years. His core experience is in Sales and International Recruitments. Ritesh is a big foodie and a huge football fan, supporting Manchester United (EPL) and FC Barcelona (La Liga). He hardly misses watching any matches when these teams are playing. Get in touch with Ritesh via: enquiry@researchbymarkets.com *Industry Press Release is a part of Research By Markets.